Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | QPCT | Q16769 | 15/20 | 0.66 |
| ▸ | QPCTL | Q9NXS2 | 3/20 | 0.41 |
| ▸ | MMP12 | P39900 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30245717 | 1.00 | QPCT (0.66) | QPCTQPCTLMMP12ALDH1A1POLB | |
| SCHEMBL30245194 | 0.92 | QPCT (0.63) | QPCTQPCTLMMP12 | |
| SCHEMBL30245326 | 0.91 | QPCT (0.64) | QPCTQPCTLMMP12POLB | |
| SCHEMBL25426407 | 0.91 | QPCT (0.64) | QPCTQPCTLMMP12POLB | |
| SCHEMBL30245421 | 0.91 | QPCT (0.74) | QPCTQPCTLMMP12ALDH1A1 | |
| SCHEMBL25426433 | 0.91 | QPCT (0.74) | QPCTQPCTLMMP12ALDH1A1 | |
| SCHEMBL25425381 | 0.88 | QPCT (0.72) | QPCTQPCTLMMP12ALDH1A1 | |
| SCHEMBL30244961 | 0.88 | QPCT (0.72) | QPCTQPCTLMMP12ALDH1A1 | |
| SCHEMBL30244877 | 0.88 | QPCT (0.49) | QPCTALDH1A1MAPT | |
| SCHEMBL25425681 | 0.87 | QPCT (0.56) | QPCTQPCTLALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023018472-A9 | AMINOARYL-INTEGRIN AGONISTS COMPOUNDS | TEXAS HEART INSTITUTE (US) | 2023-07-13 | — | — | WO | claimed |
| WO-2023018472-A9 | AMINOARYL-INTEGRIN AGONISTS COMPOUNDS | TEXAS HEART INSTITUTE (US) | 2023-07-13 | — | — | WO | disclosed |